Form D · Biotechnology
CIRC Biosciences, Inc.
Chicago, IL · CIK 0001834514
Offering snapshot reported Oct 7, 2024 · SEC filing
- Reported sold
- $250K Offering amount: $250K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Feb 1, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 7, 2024 | Initial | $250,000 | No comparison | 1 | SEC filing |
| May 1, 2024 | Initial | $7,000,000 | No comparison | 19 | SEC filing |
| Dec 7, 2020 | Initial | $16,835,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-526087
Source: Form D, filed Oct 7, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Aronin | Director |
| Sai Chavala | Director |
| Timothy Cunniff | Director |
| Antonio Gracias | Director |
| Patrick Morris | Director, Executive |
| Darien Parhad | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
400 N. Aberdeen, Suite 900
Chicago, IL, 60642
Chicago, IL, 60642